Fluvoxamine as a Cause of Stimulation, Mania, and Aggression: A Critical Analysis of the FDA-Approved Label

ISSN： 1523-150X

Source： Ethical Human Sciences and Services, Vol.4, Iss.3, 2002-01, pp. : 211-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation

By Michael N. Erfurth A.

Journal of Affective Disorders, Vol. 78, Iss. 3, 2004-03 ,pp. : 253-257

Elsevier

Access to resources Recommend Favorite

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis

By Curtin F. Schulz P.

Journal of Affective Disorders, Vol. 78, Iss. 3, 2004-03 ,pp. : 201-208

Elsevier

Access to resources Recommend Favorite

Accuracy of primary care medical providers' understanding of the FDA black box warning label for antidepressants

By Cordero Liliana

Primary Care and Community Psychiatry, Vol. 13, Iss. 3, 2008-09 ,pp. : 109-114

Informa Healthcare

Access to resources Recommend Favorite

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimer's APP 5'Untranslated Region

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 249-254

Bentham Science Publishers

Access to resources Recommend Favorite

Suicidality, Violence, and Mania Caused by Selective Serotonin Reuptake Inhibitors: A Review and Analysis

By Breggin Peter R.

Ethical Human Sciences and Services, Vol. 5, Iss. 3, 2003-01 ,pp. : 225-246

Springer Publishing Company

Access to resources Recommend Favorite